中文 | English
Return
Total: 68 , 1/7
Show Home Prev Next End page: GO
Author:(Xiu-yao XU)

1.A Preliminary Study on the Construction and Visualization of Knowledge Graph for the Ancient Chinese Medical Book Ling Shu

Ying-Xuan CHEN ; Wei-Hao XIE ; Fan CHEN ; Qian XU ; Rong-Yao LI ; Zhen-Hu CHEN ; Xiu-Feng LIU

Journal of Guangzhou University of Traditional Chinese Medicine 2024;41(3):782-790

2.Metabolomic Analysis of Mesenteric Lymph Fluid in Rats After Alcohol Gavage

Yuan ZHANG ; Zi-Ye MENG ; Wen-Bo LI ; Yu-Meng JING ; Gui-Chen LIU ; Zi-Yao HAO ; Xiu XU ; Zhen-Ao ZHAO

Progress in Biochemistry and Biophysics 2024;51(9):2194-2209

4.Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer: a prospective cohort study.

Meng XIU ; Yao LU ; Xiang WANG ; Ying FAN ; Qiao LI ; Qing LI ; Jia Yu WANG ; Yang LUO ; Rui Gang CAI ; Shan Shan CHEN ; Peng YUAN ; Fei MA ; Bing He XU ; Pin ZHANG

Chinese Journal of Oncology 2023;45(8):709-716

5.Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer: a prospective cohort study.

Meng XIU ; Yao LU ; Xiang WANG ; Ying FAN ; Qiao LI ; Qing LI ; Jia Yu WANG ; Yang LUO ; Rui Gang CAI ; Shan Shan CHEN ; Peng YUAN ; Fei MA ; Bing He XU ; Pin ZHANG

Chinese Journal of Oncology 2023;45(8):709-716

6.Antimicrobial susceptibility of Gram-positive organisms:Results from China antimicrobial resistance surveillance trial(CARST)program,2021-2022

Yun LI ; Bo ZHENG ; Feng XUE ; Xiu-Zhen ZHANG ; Yun-Jian HU ; Yu-Fen JIN ; Jian-Hong ZHAO ; Shi-Yang PAN ; Wei GUO ; Feng ZHAO ; Yun-Song YU ; Xuan CAI ; Wen-En LIU ; De-Hua LIU ; Ying FEI ; Jia-Yun LIU ; Feng-Yan PEI ; Ling MENG ; Ping JI ; Jin TANG ; Kai XU ; Lei ZHU ; Cun-Wei CAO ; He-Ping XU ; Shan WANG ; Lan-Qing CUI ; Jia ZHANG ; Yao-Yao LIU

The Chinese Journal of Clinical Pharmacology 2023;39(23):3509-3524

7.Antimicrobial susceptibility of Gram-negative organisms:Results from China antimicrobial resistance surveillance trial(CARST)program,2021-2022

Yun LI ; Bo ZHENG ; Feng XUE ; Xiu-Zhen ZHANG ; Yun-Jian HU ; Yu-Fen JIN ; Jian-Hong ZHAO ; Shi-Yang PAN ; Wei GUO ; Feng ZHAO ; Yun-Song YU ; Xuan CAI ; Wen-En LIU ; De-Hua LIU ; Ying FEI ; Jia-Yun LIU ; Feng-Yan PEI ; Ling MENG ; Ping JI ; Jin TANG ; Kai XU ; Lei ZHU ; Cun-Wei CAO ; He-Ping XU ; Shan WANG ; Lan-Qing CUI ; Jia ZHANG ; Yao-Yao LIU

The Chinese Journal of Clinical Pharmacology 2023;39(23):3525-3544

8.Relationship between body mass index and sexual development in Chinese children.

Xiao Qin XU ; Jian Wei ZHANG ; Rui Min CHEN ; Jing Si LUO ; Shao Ke CHEN ; Rong Xiu ZHENG ; Di WU ; Min ZHU ; Chun Lin WANG ; Yan LIANG ; Hui YAO ; Hai Yan WEI ; Zhe SU ; Mireguli MAIMAITI ; Hong Wei DU ; Fei Hong LUO ; Pin LI ; Shu Ting SI ; Wei WU ; Ke HUANG ; Guan Ping DONG ; Yun Xian YU ; Jun Fen FU

Chinese Journal of Pediatrics 2022;60(4):311-316

9.A cross-sectional study of prevalence of chronic kidney disease and related factors in adults in Anhui province.

Wei XU ; Xiu Ya XING ; Jing Qiao XU ; Dan CAO ; Qin HE ; Dan DAI ; Shang Chun JIA ; Qian Yao CHENG ; Yi Li LYU ; Luan ZHANG ; Ling LIANG ; Guo Die XIE ; Ye Ji CHEN ; Hua Dong WANG ; Zhi Rong LIU

Chinese Journal of Epidemiology 2022;43(11):1717-1723

10.Research of Influence on Inflammation of Xieheyin on PCOS-IR Mice Based on Intestinal Mucosal Barrier and TLR4/NF-κB/NLRP3 Pathway

Xue-fei XU ; En-li WANG ; Tian-ye YANG ; Jing-chun YAO ; Xin GONG ; Wen-yue CHEN ; Xin-yue LIU ; Guang-ci DI ; Xiu LI ; Qing-ling REN

Chinese Journal of Experimental Traditional Medical Formulae 2021;27(17):90-98

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 68 , 1/7 Show Home Prev Next End page: GO